Navigation Links
Novel Protein, Staufen2 Important In Maintenance Of Nerve Synapses

Researchers from Max Plank Institute of Developmental Biology have uncovered some of the molecular mysteries associated with synaptic connections between the neurons, that represent the structural and functional unit of the brain. //

In simple terms, the junction between two neurons is referred to as a synapse. It serves as a gateway of communication between the same. Storage and transmission of information occurs through these specialized contact sites. This synaptic connection is of great importance in the process of learning and remembering what has been learnt. These is a parallel change in the structural and functional characteristics of the synaptic junctions during the learning process. The exact molecular mechanism behind this modification has been largely unknown until now.

Michael Kiebler and his colleagues have now identified a protein called, Staufen2, found to play a significant role in the mainatenance of synaptic junctions. A cell devoid of this protein would lose a significant proportion of the synapses. Associated impairment in other contact sites and the signalling mechanism have also been identified.

The protein is known to be invloved in the transport of mRNAs to to specific locations inside a cell. This has been found to largely dependent on the recognition of the mRNA by special RNA binding proteins and the subsequent transport to synaptic junctions. As any defect in this process (due to missing Staufen2 protein) has been found to result in structural and functional inhibition of the synapse, it is logical to assume that the protein also plays a major role in the process of learning and memory retention.

This finding has obviously led to a better understanding of the molecular mechanisms behind the ability of the brain to learn and remember. If in the future, such mechanisms can be manipulated, it could lead to a revolution. Somebody who has a poor learning capacity can be substituted with an ‘ideal brain’. This could go a long way in the treatment of disorders related to learning and memory function.


'"/>




Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel test for bowel cancer
7. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
8. Novel Therapy for Chronic Problem
9. Blood Sugar Kept In Control By Novel Protein
10. Novel antibiotic dressing developed for improved wound healing
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 26, 2016 One of Australia,s ... the formation of a new biotechnology company, Noxopharm Limited [ABN 50 ... an IPO and to list on the ASX. Noxopharm ... ready to enter a Phase 1 clinical study later this year. ... address one of the biggest problems facing cancer patients - the ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
Breaking Medicine Technology: